Avita Medical (ASX: AVH) — Company Overview, News & Financial Data
Avita Medical specializes in regenerative medicine products to treat chronic wounds using innovative skin cell therapy.
Avita Medical
Avita Medical is a regenerative medicine company that develops and commercializes autologous cell therapies for acute wound care and skin restoration. Its primary focus is the development and commercialization of devices that allow healthcare professionals to prepare and administer Spray-On Skin Cells using a patient's own skin samples at the point of care. The company's therapeutic portfolio addresses acute wounds, full-thickness burns, surgical wounds, trauma, and dermatological conditions. By offering point-of-care cell delivery systems and complementary dermal and wound matrices, the company aims to expedite wound closure, minimize scar formation, reduce hospital stay durations, and improve overall patient recovery outcomes across global markets.
Snapshot
Operations
Products and/or services of Avita Medical
- Autologous Cell Suspension Systems: Medical devices that process a small skin sample at the point of care to create Spray-On Skin Cells, enabling rapid re-epithelialization and closure of severe burn injuries, full-thickness trauma, and surgical wounds.
- Biosynthetic Temporary Wound Matrices: Variable-porosity biosynthetic wound covers designed to protect acute burn and trauma sites, manage exudate, and maintain a moist healing environment until definitive skin grafting or natural tissue closure takes place.
- Collagen Dermal Matrices: Porous structural collagen matrices used to reconstruct dermal layers in complex full-thickness skin wounds, providing structural scaffold support to prepare tissue beds for definitive wound closure as early as day five post-injury.
- Clinical Development Programs: Conduct of multi-center clinical trials evaluating point-of-care autologous skin cell therapy for soft tissue reconstruction, repigmentation of stable vitiligo lesions, and expanded indications across major hospital networks.
- Surgical Burn Care Applications: Point-of-care therapeutic tools and protocols supplied to burn treatment centers and acute surgical units to reduce donor site requirements, lower infection risks, and shorten overall inpatient hospital stays.
- Global Commercial Operations: Distribution and direct sales of specialized acute wound care and skin restoration technologies to healthcare providers, trauma centers, and outpatient surgical centers across North America and key international markets.
Avita Medical executive team
- Mr. Cary G. VanceIndependent Non-Executive Chairman & Interim CEO
- Mr. David O'TooleChief Financial Officer
- Ms. Nicole Linda KelseyChief Legal & Compliance Officer and Corporate Secretary
- David MelbyeSenior Vice President of Operations
- Dr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical Affairs
- Mr. Ben AtkinsVice President of Investor Relations & Corporate Communications
- Ms. Debbie GarnerSenior Vice President of Global Marketing & Strategy
- Dr. Niraj Doshi J.D., P.M.P., Ph.D.Senior VP of R&D, Program Management and Business Development
- Mr. Ron LagerquistSenior Vice President of Quality Assurance & Regulatory Affairs
- Ms. Robin VanDenburghSenior Vice President of U.S. Commercial Sales